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ABSTRACT: Haloalkane dehalogenase (DhlA) converts haloalkanes to their corresponding alcohols and
halide ions. The rate-limiting step in the reaction of DhlA is the release of the halide ion. The kinetics of
halide release have been analyzed by measuring halide binding with stopped-flow fluorescence experiments.
At high halide concentrations, halide import occurs predominantly via the rapid formation of a weak
initial collision complex, followed by transport of the ion to the active site. To obtain more insight in this
collision complex, we determined the X-ray structure of DhlA in the presence of bromide and investigated
the kinetics of mutants that were constructed on the basis of this structure. The X-ray structure revealed
one bromide ion firmly bound in the active site and two bromide ions weakly bound on the surface of the
enzyme. One of the weakly bound ions is close to Thr197 and Phe294, near the entrance of the earlier
proposed tunnel for substrate import. Kinetic analysis of bromide import by the Thr197Ala and Phe294Ala
mutants of DhlA at high halide concentration showed that the rate constants for halide binding no longer
displayed a wild-type-like parabolic increase with increasing bromide concentrations. This is in agreement
with an elimination or a decrease in affinity of the surface-located halide-binding site. Likewise, chloride
binding kinetics of the mutants indicated significant differences with wild-type enzyme. The results indicate
that Thr197 and Phe294 are involved in the formation of an initial collision complex for halide import in
DhlA and provide experimental evidence for the role of the tunnel in substrate and product transport.
Haloalkane dehalogenase (DhlA)1 from Xanthobacter
autotrophicus hydrolyzes carbon-halogen bonds of a broad
range of n-haloalkanes (1). As many of these compounds
are toxic xenobiotics which occur as soil and groundwater
pollutants, DhlA is an interesting enzyme from an environ-
mental perspective. Its structure and catalytic mechanism
have been studied in detail (2-9). The enzyme consists of
a main domain (residues 1-155 and 230-310) with an R/â-
hydrolase fold (10) and a cap domain comprising five
R-helices (residues 156-229). The dehalogenation reaction
takes place in the active-site cavity which is buried inside
the enzyme between the two domains. The catalytic triad
residues Asp124, His289, and Asp260 stand out from the
main domain, whereas residues from the cap domain govern
the substrate specificity (11).
The four-step reaction mechanism of the enzyme begins
with the formation of a Michaelis complex, after which a
covalent alkyl-enzyme intermediate is formed by nucleo-
philic attack of Asp124 on the substrate and a halide ion is
cleaved off. During the reaction, the halide moiety is
stabilized by the indole NH groups of Trp125 and Trp175
between which it is bound. Then the covalent intermediate
is hydrolyzed yielding an alcohol product which is rapidly
released from the cavity. In the rate-limiting last step, the
halide ion is removed from the cavity. From stopped-flow
fluorescence analysis of bromide import, Schanstra et al. (12)
concluded that the enzyme employs two different routes for
halide import/export that operate in parallel (Scheme 1). At
low bromide concentrations (1-20 mM) the import is
dominated by the faster upper route which consists of a slow
unimolecular isomerization step, followed by a rapid bimo-
lecular step and a second enzyme isomerization. Site-directed
mutagenesis experiments in combination with X-ray crystal-
lographic studies have shown that mutations in the cap
domain of DhlA may increase the rate of the enzyme
isomerization step in the upper route and lead to faster halide
release (13-15). At higher bromide concentrations (20-1000
mM) a slower lower route for halide binding can also be
observed, involving a fast bimolecular step preceding a slow
enzyme isomerization. The bimolecular step has been
explained as the rapid binding of a bromide ion into an initial
“collision complex” with the enzyme, (E.X-)* in Scheme
1. Likewise, data for chloride show the same two routes for
import, although the occurrence of a collision complex was
uncertain (Scheme 2) (12). Such kinetically observed colli-
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for Chemical Research (SON) with financial aid from The Netherlands
Organization for Scientific Research (NWO). M.P.G. and I.S.R.
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sion complexes have been found with other enzymes as well
(16), although their structure is often unknown.
To obtain more insight in the nature of the collision
complex occurring in the lower route of halide import, we
studied the X-ray structure of haloalkane dehalogenase in
the presence of a high concentration of bromide. Assuming
that halide import and export follow the same pathway, this
structure would provide valuable information about halide
export from the enzyme. The structure was determined at
pH 5.9 as it was known that the dissociation constant of the
halide decreases at lower pH (12). The secondary bromide-
binding site that was most likely to represent the collision
complex was further examined by site-directed mutagenesis
studies followed by kinetic characterization of the mutants
to investigate their influence on halide transport.
MATERIALS AND METHODS
Preparation of Haloalkane Dehalogenase Crystals and
Diffraction Data Collection. Haloalkane dehalogenase was
crystallized in hanging drop setups at room temperature using
the vapor diffusion method as described previously (17). The
drops consisted of 4 íL of 5.5 mg/mL protein in 100 mM
MES [2-(N-morpholino)ethanesulfonic acid] buffer, pH 5.7-
5.9, mixed with an equal volume of reservoir solution.
Crystals were obtained within 2 weeks from 47-53%
ammonium sulfate in 100 mM MES buffer (pH 5.9). One
crystal was soaked in a solution of 0.5 M sodium bromide
and 60% (NH4)2SO4 in 100 mM MES buffer (pH 5.9) for
about 30 min at room temperature. From this crystal a
diffraction data set was collected at 120 K with a MacScience
DIP-2030H image plate area detector system, receiving
graphite monochromatized Cu KR radiation (ì ) 1.5418 Å)
from an FR591 rotating anode X-ray generator through a
double mirror focusing system (model MAC-XOS). A
solution of 30% (w/v) PEG 6000, 25% (v/v) glycerol, and
100 mM MES buffer (pH 5.9) was applied as a cryopro-
tectant. Data were integrated and merged with DENZO/
SCALEPACK (18). The crystal belonged to the orthorhom-
bic space group P21212, with cell axes a ) 93.4 Å, b )
72.0 Å, and c ) 41.0 Å. It was isomorphous to the wild-
type crystals and had a mosaic spread of 1.3°. Further
information on the data processing is given in Table 1.
Structure Solution and Crystallographic Refinement. The
structure of the wild-type DhlA at pH 5.0 [PDB entry 1BE0
(15)] without solvent molecules was used as the starting
model for refinement with X-PLOR version 3.843 (19). The
test-set of 5% of the unique reflections was preserved to
calculate Rfree values (20) as an independent validation of
the refinement progress. First, a rigid body refinement was
done to position the molecule more precisely in the asym-
metric unit. This resulted in a significant drop in Rfree, which
decreased from 43.1 to 33.9% (15-2.3 Å data). Then several
rounds of positional and B-factor refinement were applied
(data 20-2.3 Å), making use of a bulk-solvent mask in
X-PLOR. Water molecules were placed manually with O
(21) upon inspection of OMIT Fo-Fc electron density maps
(22, 23) at positions corresponding to g3ó (0.3 e Å-3)
spherical density with correct geometry.
Three “water molecules” were identified as bromide ions
on the basis of additional positive Fo-Fc electron density
and a B-factor of 2.0 Å2sthe X-PLOR default minimum
valuesafter refinement, much lower than the mean B-value
of the direct surroundings of the molecules. When the model
was adjusted accordingly, the B-factors of the ions refined
to values higher than those of their environment and the Rfree
decreased by about 1%. As a control, refinements were
carried out with each bromide ion replaced by a water
molecule and an arbitrary water molecule by a bromide ion.
In all cases this led to unrealistic B-values (99 Å2 for the
“bromide instead of water” and 2.0 Å2 for the “water instead
of bromide”) and an approximately 0.5% higher Rfree. The
B-factors of the bromide ions in the final model are 18, 44,
and 48 Å2 for Br1, Br2, and Br3, respectively,
At all stages OMIT 2Fo-Fc and Fo-Fc electron density
maps were calculated and inspected with O to check the
agreement of the model with the data. PROCHECK (24) and
WHATCHECK (25) were used to assess the stereochemical
quality. Whenever necessary the model was manually
adjusted with O. The refinement was stopped when it gave
no further decrease in Rfree or improvement in stereochem-
istry. A last cycle of refinement including all data from 20
to 2.30 Å resolution was used to make some final corrections.
In a Ramachandran plot of the complex structure, 96.2% of
the residues is found inside the core region as defined by
Kleywegt and Jones (26). The atomic coordinates and
structure factor amplitudes have been deposited in the Protein
Data Bank (PDB) (27) with the entry code 1CIJ.
Mutagenesis and DNA Sequencing. Site-directed mutagen-
esis was performed according to Kunkel (28). Escherichia
coli strain BW313 was used for the production of single
stranded DNA of plasmid pGELAF(+) (29), a derivative of
pET-3d. The primer used to mutate Thr197 to Ala was
CGTTGGGCCCCCGCACTGACC, with the mutated codon
italicized. The mutated nucleotides (bold) caused the removal
of a unique NarI site. For the mutation of Phe294 to Ala the
primer was GTACAGGAGGCCGGCGAGCAA, with the
mutated codon in bold and the introduced NaeI restriction
site underlined. The primer used to mutate Phe294 to Trp
was GTACAGGAGTGGGGCGAGCA. The mutated codon
Scheme 1
Scheme 2
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is shown in bold, and initial confirmation of the mutation
was obtained by PCR with suitable control primers. The
oligonucleotides for mutagenesis were supplied by Eurose-
quence BV, Groningen, The Netherlands. Sequences of
mutated genes were established by the Center for Biomedical
Technology, University of Groningen, Groningen, The
Netherlands.
Protein Expression and Purification. E. coli strain BL21-
(DE3) (30) was used for expression of mutant dehalogenases
as described before (29) with some minor alterations.
Transformants, precultures, and main cultures were grown
at 30 °C to an OD600 of 1.0. Then IPTG was added and
growth was continued for 14-20 h at 18 °C. Crude extract
was prepared as described earlier (29). The buffer used
during purification was TEMAG (10 mM Tris-sulfate, pH
7.5, 1 mM EDTA, 1 mM 2-mercaptoethanol, 3 mM sodium
azide, and 10% (v/v) glycerol). After passage through an
0.2 ím filter, crude extract was applied to a Resource Q
column (Pharmacia Biotech). Bound protein was eluted using
buffer with a gradient of 0-0.5 M ammonium sulfate.
Depending on the purity of the resulting enzyme protein an
additional purification step was performed as follows: The
fractions containing the dehalogenase were pooled and the
ammonium sulfate concentration was increased up to 1.5 M.
This solution was syringe filtered again and loaded on a
Resource Iso or Resource Phe hydrophobic interaction
column (Pharmacia Biotech), depending on the mutant.
Protein was eluted using a 1.5-0 M ammonium sulfate
gradient. Purified protein was analyzed with SDS-poly-
acrylamide gel electrophoresis using Coomassie brilliant blue
staining and stored at 4 °C in TEMAG without ammonium
sulfate.
Dehalogenase ActiVities. Specific dehalogenase activities
were assayed using colorimetric detection of halide release
(1). Km values were determined by measuring initial rates
of alcohol production using gas chromatography. The
uncertainty in Km and kcat was estimated at (20%. Samples
were analyzed on a Chrompack 438S gas chromatograph
using a CPWax 52CB column (Chrompack, Middelburg, The
Netherlands), coupled to an ECD or FID detector for
brominated or chlorinated products, respectively. Protein
concentrations were determined with Coomassie brilliant blue
using bovine serum albumin as a standard.
Stopped-Flow Fluorescence Studies. Stopped-flow fluo-
rescence quenching measurements were performed as de-
scribed before (12). Each trace was fitted to a single
exponential with a program implemented in the stopped-flow
instrument software. Numerical fitting of these single ex-
ponentials to a halide-binding scheme with the program
Scientist (version 2.0, MicroMath Inc.) revealed rate con-
stants for individual binding steps. With these individual rate
constants the observed rate constant for any concentration
could be determined by analyzing the output of the Scientist
simulation in Quattro Pro (version 6.01, Borland International
Inc.). The current method used to fit the obtained kobs data
was more accurate than the method used by Schanstra and
Janssen (12), which resulted in wild-type data that show some
minor differences from formerly published results.
RESULTS
X-ray Structure of Haloalkane Dehalogenase with Bromide
Bound. To study the structural details of secondary halide
binding at high halide concentrations, we determined the
X-ray structure of the enzyme soaked in a 0.5 M sodium
bromide solution. The starting model (wild-type dehaloge-
nase at pH 5.0) had to be adjusted only slightly during the
crystallographic refinement procedure. Three bromide ions
could be modeled convincingly into difference Fourier
electron density (Figure 1). After completion of the refine-
ment, the crystallographic R-factor was 22.6% for all data
between 20 and 2.3 Å. The final model contained one
complete dehalogenase molecule of 310 amino acid residues,
3 bromide ions, and 160 water molecules. The mean
coordinate error estimated from a óA plot (31) was 0.3 Å.
Like in the wild-type structure, the Ramachandran plot
showed two outliers, Asp124 and Asn148, in generously
allowed regions. Parameters indicating the stereochemical
accuracy of the final model are given in Table 1.
The three-dimensional structure of the enzyme with
bromide bound is very similar to the apo-structure at pH
6.2 and room temperature (3). The rms difference of all CR
coordinates is only 0.29 Å, and this difference cannot be
attributed to a specific region. The catalytic triad, formed
by residues Asp124, His289, and Asp260, is intact, and all
other amino acids surrounding the active-site cavity are in
an orientation comparable to that in the apo-structure. The
nucleophilic water molecule is not clearly discernible,
however. This is probably caused by the lower resolution of
the bromide-bound dehalogenase data.
Table 1: Statistics of Data Collection and Quality of the Final Model of Haloalkane Dehalogenase with Bromide Bound
data collctn statistics quality of the final model
cell dimensions (Å) a ) 93.4, b ) 72.0, final R-factor (%) 22.6 (20-2.3 Å)
c ) 41.0 free R-factor (%) 27.2 (20-2.3 Å)
resolution range (Å) 50-2.30 no. of atoms
(highest resolution shell) (2.34-2.30) protein 2478
tot. no. of observations 34 663 bromide 3
no. of unique reflections 12 688 solvent 160
completeness (%) 97.6 rmsd from ideality for
(highest resolution shell) (98.2) bond lengths (Å) 0.009
<I/ó(I)> 8.0 bond angles (deg) 1.6
(highest resolution shell) 2.1 dihedrals (deg) 24.2
Rmerge (%)a 10.8 impropers (deg) 1.2
(highest resolution shell) (36.3) ¢B bonded atoms (Å2) 3.0
B-factor (Å2)b 19.5 <B> overall (Å2) 16.2
est. coord error (Å)c 0.3








< I(hkl)>}. b Derived from Wilson plot statistics (52). c Derived from óA plot (31).
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Inside the active-site cavity a bromide ion (Br1) is bound
between the indole nitrogen atoms of Trp125 and Trp175 at
a distance of 3.5 and 3.3 Å, respectively (Figure 2A). It is
located at a position that is occupied by a water molecule in
the apo-structure. Previously, Verschueren et al. (32) have
observed halide ion binding at the same position for a
chloride and iodide ion. In these cases the distances to the
N1 atoms of Trp125 and Trp175 were 3.3 and 3.4 Å for
the chloride ion (estimated coordinate error 0.13 Å) and 3.8
and 3.4 Å for the iodide ion (estimated coordinate error 0.17
Å). In an extensive search of the Cambridge Structural
Database (CSD (33)), Nsp2âââhalide distances are reported
of 3.181(6), 3.35(1), and 3.65(2) Å for chloride, bromide,
and iodide ions, respectively (34). When compared to the
average distances in the DhlA active site, it is seen that the
average distance for the two larger ions is in agreement with
the CSD values, but for chloride the CSD value is somewhat
shorter than found in the protein structure (32). This suggests
that the halide-binding site in DhlA is less optimal for
chloride than for bromide and iodide ions. Other amino acid
residues that are within 4 Å distance of the bromide ion are
Glu56, Phe172, Phe222, Pro223, and Val226 (Figure 2A).
Inside the cavity also one water molecule is found that is
hydrogen bonded to the ion. It is close to the position of the
second water molecule in the pH 6.2 apo-structure.
Secondary Bromide Binding to DhlA. At the surface of
haloalkane dehalogenase two other bromide ions are bound
(Figure 1). The first, Br2, is located at the interface of the
cap and main domains between the loop connecting helices
R6 (residues 187-194) and R7 (residues 200-208) in the
cap domain and the loop connecting strand â8 (residues
282-284) and helix R11 (residues 291-308) in the main
domain of the enzyme. This is close to the entrance of the
tunnel that was proposed to be involved in substrate import
(2) (Figure 3). The ion is hydrogen bonded to the hydroxyl
group of the Thr197 side chain, at a distance of 2.9 Å. This
is somewhat shorter than the Xâââhalide contacts in the CSD,
where for a Csp3-OH donor distances to chloride and
bromide ions have been reported of 3.100(4) and 3.254(8)
Å, respectively (34). It is also hydrogen bonded to a water
molecule at 3.2 Å. This value is similar to the distances of
3.190(3) and 3.339(7) Å for chloride and bromide ions
observed by Steiner (34). Other amino acid residues within
4 Å distance of Br2 are Ala195, Pro196, and Phe294 (Figure
2B). The structure of this region closely resembles that of
the apo-enzyme, except for the Thr197 side-chain atoms,
which have rotated 0.6-1.0 Å inward. In the pH 6.2 apo-
structure a water molecule is found close to the position of
the bromide ion, at a distance of 0.4 Å. It makes short
hydrogen-bonding contacts with two other water molecules
that are 2.5 and 2.6 Å away, respectively.
A second bromide ion binding site at the surface of the
enzyme (Br3) is found in the cap domain between the loop
connecting helices R5 (residues 171-181) and R6 (residues
187-194) and the loop connecting helices R7 (residues 200-
208) and R8 (residues 217-227) of the enzyme. The ion is
bound to the amide nitrogen atom of the Gln216 side chain
and the main-chain amide nitrogen atom of Leu187 at a
distance of 3.3 Å to both. This is very close to the distances
observed for these types of donors in organic crystal
structures, 3.299(6) and 3.46(1) Å to chloride and 3.181(6)
and 3.35(1) Å to bromide, respectively (34). Br3 also makes
electrostatic interactions with a water molecule at 3.3 Å.
Other amino acid residues within 4 Å distance of Br3 are
Leu185, Ala207, and Phe210 (Figure 2C). The structure in
the vicinity of the bromide ion is very similar to that of the
apo-enzyme in this region. In the pH 6.2 apo-structure a
water molecule is found close to the corresponding position
of the bromide ion, at a distance of 0.6 Å, and a hydrogen-
bonded water molecule is found at 2.9 Å.
Both bromide ions that are found on the outside of the
haloalkane dehalogenase are bound in a shallow depression
in the surface of the molecule. Only a few electrostatic
interactions contribute to binding, none of them from
positively charged amino acid side chains. Instead, binding
interactions are provided by predominantly apolar residues
such as alanine, proline, and phenylalanine. The latter is
involved in binding via the partially positively charged edge
of its aromatic ring. In the apo-enzyme, the bromide binding
sites are occupied by water molecules. When compared to
the apo-enzyme, the protein structure is nearly unperturbed
and only the neighboring water molecules have moved away
FIGURE 1: Stereoview of the location of the halide-binding sites in haloalkane dehalogenase. DhlA is represented as a CR-trace with every
tenth residue depicted as a small sphere and every twentieth residue labeled. Active site residues are drawn as sticks and the bromide ions
as balls. This and the following figure were prepared with MOLSCRIPT (53).
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from the position of the bromide ion. The weak nature of
the binding interactions and the B-factors of both ions, 44
and 48 Å2 for Br2 and Br3, respectively, suggest that the
binding of bromide ions at the surface is not as tight as in
the primary halide-binding site between Trp125 and Trp175.
Halide Binding in Other Protein Structures. A large
number of halide-complexed structures are available in the
PDB, most of them containing chloride. The halide ions are
often found to act as (weak) inhibitors when the protein is
in solution (35-37). Functionally relevant chloride-binding
sites were found in the X-ray structures of hemocyanin (38),
hemoglobin Rothschild (39), and porcine R-amylase (40, 41).
In the analysis of bromide binding in various proteins, it
appears that the ions are bound mostly to main-chain amide
groups and to the hydroxyl groups of serine and threonine
residues. In some cases binding to arginine, lysine, or
FIGURE 2: Stereoviews of the three halide-binding sites in haloalkane dehalogenase. Relevant residues described in the text are drawn as
balls-and-sticks and parts of the CR-trace as a coil. All electrostatic interactions of the bromide ion with residues within 3.5 Å are depicted
as dotted lines. The bromide-bound structure is represented in black, and the apo-structure, in gray. (A) Bromide binding in the active site.
The bromide ion (Br1) is stabilized by Trp125 and Trp175. One water molecule (W) is depicted as well. (B) Secondary bromide binding
at the surface between main domain and cap domain. The bromide ion (Br2) is bound to Thr197 and a water molecule (W). (C) Secondary
bromide binding at the surface in the cap domain. The ion (Br3) is held in position by Gln216 and Leu187.
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histidine is observed as well as to the positively charged edge
of an aromatic ring of a tyrosine or tryptophan residue.
Furthermore, a few van der Waals interactions to apolar
residues and many interactions with water molecules are
found. Thus it is clear that there is not one preferred
architecture for a bromide-binding site. The three different
bromide ion binding sites in DhlA are in agreement with
these findings.
Site-Directed Mutagenesis. Of the two secondary bromide-
binding sites, Br2 is the most likely one to correspond to
the kinetically observed collision complex since it is close
to the entrance of the proposed tunnel for substrate import.
Moreover, in a recent diffraction experiment a chloride ion
was found at this binding site but not at the Br3 site (42).
To test the importance of Br2, three mutants were con-
structed: Thr197Ala, Phe294Ala, and Phe294Trp. The first
two were chosen because the side chains of Thr197 and
Phe294 are in close contact with the ion and changing these
residues into alanines would weaken or eliminate the binding
site. To study the effect of a more conservative mutation,
Phe294 was also replaced by a tryptophan. All mutant
proteins could be produced very efficiently, with expression
levels exceeding 20% of the total soluble protein and with
no indication of aggregation in inclusion bodies. The
purification yielded about 200 mg of pure protein/L of culture
fluid, and the active mutant enzymes could be stored at 4
°C for over 3 months without loss of activity.
The kinetic properties of the Thr197Ala and Phe294Ala
mutants were almost similar to those of the wild-type enzyme
(Table 2). Both mutants showed a slightly lowered kcat for
1,2-dibromoethane and 1,2-dichloroethane, whereas the Km
values for these substrates were identical to the wild type.
This suggested that there were no significant differences in
the structure of the active site. This was also established by
the fact that the dissociation constants for chloride and
bromide varied only a little from the wild-type data.
The Phe294Trp mutant, however, was no longer capable
of binding substrate, although CD measurements (not shown)
indicated that this mutant was properly folded. Halide binding
only seemed to occur at very high concentrations with an
aspecific mechanism, possibly causing quenching only of
the introduced tryptophan residue at the surface of the
protein.
Bromide Binding Kinetics. The kinetic mechanism of
halide binding has been well characterized for the wild-type
enzyme using stopped-flow fluorescence (12). Binding of a
halide ion in the active site quenches the fluorescence of
the two active-site tryptophan residues, resulting in single-
exponential traces from which the kobs value can be deter-
mined. The dependence of kobs on bromide concentration is
shown in Figure 4. At low concentrations, binding occurs
after a slow unimolecular isomerization of the enzyme
(Scheme 1, upper route), which results in the decrease of
kobs with increasing bromide concentrations. The parabolic
increase of kobs with halide concentrations observed at higher
concentrations is due to the rapid formation of a low-affinity
collision complex, followed by a slow unimolecular isomer-
ization step (Scheme 1, lower route).
To determine the role of the second bromide binding site
in halide binding and release, purified Thr197Ala and
Phe294Ala mutant enzymes were subjected to stopped-flow
fluorescence halide-binding studies with chloride and bro-
mide. Halide binding was examined over a concentration
range of 1-1000 mM. As with the wild-type enzyme, all
obtained fluorescence traces could be fitted to single expo-
nentials.
FIGURE 3: View of the proposed tunnel in haloalkane dehalogenase.
DhlA is represented as a CR-trace with active-site residues and
bromide ions drawn as balls-and-sticks. The entrance of the tunnel
leading from the surface to the active site is located above the
bromide binding site Br2. The tunnel is blocked by the side chains
of Trp194 and Leu262. This figure was prepared with VOIDOO
(54) and BOBSCRIPT (55).
Table 2: Steady-State Kinetic Constants of Wild-Type, Thr197Ala,
and Phe294Ala Mutant Haloalkane Dehalogenase
Kd (mM) Km (mM) kcat (s-1)
Cl- Br- DCE DBE DCE DBE
wild type 75 10 0.50 0.01 3.3 3.0
Thr197Ala 68 9 0.50 0.01 2.4 2.1
Phe294Ala 50 13 0.50 0.01 1.6 2.2
FIGURE 4: Bromide binding kinetics of Thr197Ala (0, dotted line)
and Phe294Ala (4, dotted line) haloalkane dehalogenase compared
to the wild type (b, solid line). The lines show the best fits to
Scheme 2 for the mutants and Scheme 1 for the wild type. The
corresponding rate constants are summarized in Table 3.
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The kobs values for the mutants in the low concentration
region are somewhat lower than for wild type (Figure 4,
inset), but they still show a decrease with increasing bromide
concentrations. This indicates that at low concentrations
bromide binding still takes place according to the wild-type
mechanism, with a slow unimolecular isomerization proceed-
ing a rapid binding step. At high concentrations, however,
the mutants appear to exhibit an alternative kinetic mecha-
nism. The parabolic concentration dependence in the wild-
type enzyme, which was modeled by assuming the formation
of a collision complex that occurred before a slow isomer-
ization step (E.X- in Scheme 1, lower route) has changed
into a linear concentration dependence for both mutants.
When only the lower route of the binding scheme is
considered, the part of the kobs vs bromide concentration
curve representing binding at high halide concentrations can
be described as (43)
with kobs changing from a minimum of k-5 to a maximum
of k-5 + k5. The absence of a saturation phase at high
concentrations observed for the two mutants indicates that
the surface-located binding site responsible for the formation
of the collision complex is either eliminated or has a
decreased affinity for bromide ions. The resulting linear
increase can be described with a bimolecular association
(lower route in Scheme 2), according to
Irrespective of whether a weak binding site is still present
or not, the linear increase of kobs at high bromide concentra-
tions, which does not approach saturation at the concentra-
tions used, clearly shows that Thr197 and Phe294 are
involved in bromide binding via the lower route of the
binding scheme.
Bromide binding to the mutant enzymes could be fitted
over the complete concentration range with a simplified,
4-step binding scheme (Scheme 2), whereas a 5-step binding
scheme (Scheme 1) was needed for the wild type. The kinetic
constants of the individual binding steps were obtained by
numerical fitting. The resulting data (Table 3) show that the
deviation of the kobs values for bromide binding of the two
mutants compared to wild type observed at low concentra-
tions (Figure 4) is caused by a decrease of k-3 and a slight
increase of k1. Since halide release is the slowest step in the
dehalogenation cycle of the wild-type enzyme, the decrease
in k-3 could explain the lowered kcat with DCE and DBE
that was observed for the two mutants. The increase in k1
may imply a shift in the equilibrium between the two
unliganded conformations of the protein. The nature of the
difference between these two conformations is unknown, so
it is not possible to comment on how the mutations could
influence the transition between these two forms and why
the Thr197 mutation has a larger effect than the Phe294
mutation.
The linear increase at high bromide concentrations ob-
served for the two mutants implies that kobs depends on k6
and k-6 (eq 2). To compare these kinetic constants with wild-
type values, the concentration dependence of kobs for wild-
type bromide binding was fitted to the 4-step scheme, using
concentrations up to 600 mM, since these values fall in the
linear part of the curve. As the kobs curves of Thr197Ala
and wild-type enzyme are similar in this concentration range,
k6 and k-6 are almost identical for these enzymes. The kobs
curve of the Phe294Ala mutant enzyme, however, indicates
a significant increase in both kinetic constants, which implies
that the mutation not only affects the binding site but also
influences halide transport to and from the active-site
tryptophans.
When the collision complex is only weakened by the
mutations and bromide binding to the mutants still occurs
according to Scheme 2, K4 will show an increase. From eq
1 it is clear that this would lead to a decrease in kobs. The
Thr197Ala mutant however shows almost similar kobs values
in the high concentration range and the kobs values of the
Phe294Ala mutant in this region display even a significant
increase compared to the wild type. This implies that both
mutations also affect k5 and/or k-5, the rate constants that
represent halide transport to and from the active site. It is
most likely that bromide binding at high concentrations still
occurs via a two-step mechanism, since the apparent second-
order rate constant is not very high. When this rate constant
is lower than 10-9 M-1âs-1, the rate of diffusion-limited
binding (43), this is generally believed to be caused by the
occurrence of an initial collision complex (16). However,
the possibility that such a weak collision complex is formed
cannot be assessed kinetically as the enzyme is not stable in
solutions containing over 1 M halide.
Chloride Binding Kinetics. For wild-type DhlA the kinetic
mechanism of chloride binding is similar to the mechanism
for bromide. The only significant difference arises in the
lower route, which does not saturate at high chloride
concentrations (Figure 5). The kobs curves could therefore
be fitted to a 4-step binding scheme (Scheme 2).
Despite the absence of a kinetically detectable collision
complex in the wild-type enzyme, the mutations do influence
chloride binding kinetics (Figure 5). The deviation of kobs at
low concentrations can be attributed to the decrease in k-3
and the increase in k1, like it was also observed with bromide
binding. As with bromide binding, the decrease in k-3 is
likely to cause the decrease in specific activity.
Table 3: Kinetic Rate Constants of Halide Binding, Where Data Represent the Best Fit to either Scheme 1 or 2
k1 (s-1) k-1 (s-1) k3 (s-1) k-3 (s-1) K4 (mM) k5 (s-1) k-5 (s-1) k6 (mM-1âs-1) k-6 (s-1) Kd (mM)
Br- wild-type 2.9 ( 0.3 >290 >930 9.3 ( 0.5 1500 ( 300 111 ( 5 0.60 ( 0.3 10 ( 1
Thr197Ala 3.9 ( 0.4 >390 >470 4.7 ( 0.4 0.052 ( 0.005 0.42 ( 0.02 9 ( 1
Phe294Ala 3.2 ( 0.3 >320 >560 5.6 ( 0.4 0.070 ( 0.007 0.88 ( 0.05 13 ( 1
wild-typea 3.4 ( 0.3 >340 >860 8.6 ( 0.5 0.054 ( 0.005 0.44 ( 0.02 10 ( 1
Cl- wild-type 3.2 ( 0.3 >320 >1200 17.3 ( 0.7 0.009 ( 0.005 0.58 ( 0.05 75 ( 5
Thr197Ala 4.4 ( 0.4 >440 >830 8.3 ( 0.5 0.011 ( 0.001 0.70 ( 0.06 68 ( 5
Phe294Ala 3.4 ( 0.3 >320 >1070 10.7 ( 0.5 0.013 ( 0.01 0.68 ( 0.06 50 ( 5
a Fit performed only on concentration range 1-600 mM.
kobs ) k-5 + k5[X-]/([X-] + K4) (1)
kobs ) k6[X-] + k-6 (2)
12058 Biochemistry, Vol. 38, No. 37, 1999 Pikkemaat et al.
Both mutants show an increase of k6 as well as of k-6,
which causes an increased kobs at high chloride concentra-
tions. As with bromide binding, the lower route is not
diffusion limited, so we can assume that the employed
mechanism in this case is also accurately represented by eq
1. The increase of kobs with chloride binding of the mutant
enzymes compared to the wild type, however, is more
pronounced than in case of bromide binding. Since the
collision complex is much weaker with chloride, the effect
of weakening the collision complex (increasing K4) on kobs
is expected to have a much smaller effect on chloride binding
kinetics. The increase of kobs can therefore be mainly
attributed to an increase of k5 and/or k-5.
DISCUSSION
Halide ion export is the last and rate-limiting step in the
reaction catalyzed by haloalkane dehalogenase (7). Two
different routes that operate in parallel have been identified
for the reverse process (12), one of them involving a slow
enzyme isomerization preceding rapid binding of the halide
ion. This upper route in Scheme 1 is predominant at low
halide concentration, while at high concentration import is
dominated by a two-step mechanism, initiated by a rapid
bimolecular binding step followed by a slow isomerization
(lower route in Scheme 1). From thermodynamic analysis
of these two reversible routes Krooshof et al. (44) suggested
that the first step in the lower route involved the formation
of a low-affinity surface-located collision complex. In the
present article, we have studied the nature of this collision
complex by crystallographic analysis of DhlA at high
bromide concentration and by performing kinetic studies with
site-directed mutants that were constructed on the basis of
this structure.
Inspection of the X-ray structure shows that two halide-
binding sites are present on the surface of the enzyme in
addition to the known halide-binding site between Trp125
and Trp175 in the active-site cavity (Figure 1) (32). The
presence of those sites on the surface is in agreement with
the observation that formation of the collision complex is a
fast process. Both bromide ions are bound via only a few
charge-polar and van der Waals interactions which, together
with their high B-values, suggests that binding is not very
strong. This is supported by the fact that halide binding at
these positions was not observed in previous X-ray studies
performed at lower halide concentrations (4, 32).
The slow step in the lower route for halide binding is an
isomerization of the halide-enzyme complex, during which
the halide ion is transported to the active-site cavity. The
distance from the two secondary binding sites Br2 and Br3
to the active-site position Br1 is about 16 Å for both sites.
Visual inspection of the structure provides no obvious
pathway leading from Br3 to Br1. Following the straight line
from Br3 to Br1 would require the ion to move past the side
chains of the apolar residues Leu187, Val219, and Pro57
and almost through the Glu56 side chain. The latter residue
is firmly held in position by a hydrogen bond from the
protonated Glu56 O2 to Val219 O, which is present even
at pH 8.2 (3).
On the other hand, an ion moving along the direct path
from Br2 to Br1 would pass along the side chains of Phe290,
His289, and Trp175. These residues are at least partially
aromatic and are known to be able to stabilize negatively
charged groups such as sulfur and oxygen by an interaction
with the positively charged edge of their aromatic rings (45).
Using their rotational freedom, the side chains could exhibit
a guiding function for the halide ion without disrupting the
overall structure of the enzyme too much. Moreover, this
path would closely follow the tunnel leading to the active
site which was proposed to play a role in substrate import
and product export (2) (Figure 3). The surface binding site
Br2 is only about 8 Å away from the entrance of this tunnel.
Since it is charged, the bromide ion is not likely to “diffuse”
through the protein as can occur with apolar compounds (46).
Hence it is likely that the halide transport path runs through
the tunnel, as this would imply only a small deviation from
the straight route from Br2 to Br1. In this way, the X-ray
structure provides experimental evidence for the tunnel as a
route for halide import and export. It is conceivable that
substrate import follows the same path, although in this case
formation of a collision complex was never observed (7).
Evidence that the surface binding site Br2 is the location
of the halide-enzyme collision complex is also provided
by the characterization of the Thr197Ala and Phe294Ala
mutants of haloalkane dehalogenase. In contrast to wild-type
enzyme, at high halide concentration both mutants show a
kobs of halide binding which increases linearly with increasing
halide concentrations. The third mutant that was constructed,
Phe294Trp, showed an aberrant binding behavior, both for
substrate and halide. It is difficult to understand how the
introduction of a larger residue at the enzyme’s surface is
related to an apparent disturbance of the binding interaction
between the active-site tryptophans and the substrate or
halide, which are 16 Å away from the mutated residue. On
the basis of calculations of molecular interaction fields
between DhlA and halide ions, Krooshof et al. (47) suggested
that Lys259 and Lys261 were likely candidates to form the
collision complex. However, the X-ray structure presented
in this article as well as site-directed mutants of these two
residues (M. G. Pikkemaat, unpublished results) do not
indicate the involvement of Lys259 or Lys261 in the
formation of the collision complex.
The function of the tunnel in halide transport is also
supported by experiments of Krooshof et al. (47), who
constructed an Asp260Asn-Asn148Glu double mutant which
FIGURE 5: Chloride binding kinetics of Th197Ala (0, dotted line)
and Phe294Ala (4, dotted line) haloalkane dehalogenase compared
to the wild type (b, solid line). The lines show the best fits to
halide binding Scheme 2. The corresponding rate constants are
summarized in Table 3.
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showed a 12-fold increase in the rate of bromide binding
and release. They proposed that this was caused by the
repositioning of the negative charge from residue 260 to 148,
which moves the charge further away from the tunnel, thus
facilitating the passage of a halide ion. It is also consistent
with the results of a thermodynamic analysis of the two
halide-binding routes, from which it was concluded that this
halide-transport step probably does not require large struc-
tural rearrangements, unlike the upper route in Scheme 1
which was proposed to start with a major conformational
change (44).
The kinetic pattern of halide binding to haloalkane
dehalogenase is in agreement with the formation of an initial
collision complex according to a rapid binding equilibrium,
followed by a slow unimolecular enzyme isomerization step.
This pattern of ligand binding is observed with many
enzymes, although the structure of the collision complex,
the kinetics of its formation, and the events that occur during
binding are usually unknown (16, 48, 49). Since rapid-mixing
methods are only capable of determining rates of up to 1000
s-1, the formation of a collision complex is often not
kinetically accessible, and the observed binding step repre-
sents the subsequent unimolecular enzyme isomerization
(16). Such a rearrangement can vary from repositioning of
the substrate or minor side-chain motions to major confor-
mational changes such as a loop closure (16, 48). The
collision complex is also not easy to observe by structural
methods, since the isomerization step often cannot be
inhibited and from a thermodynamic point of view the final
conformation is more favorable. In the case of haloalkane
dehalogenase, the site forming the collision complex ap-
peared to be located on the surface, which is in agreement
with the observation that the complex is rapidly formed even
though the active site is a buried internal cavity. Due to the
separate locations of the internal binding site and the external
collision complex site, simultaneous occupancy is possible,
which allowed determination of the X-ray structure of the
complex.
Our results indicate that the conformational change leading
to definitive binding probably is a translocation of the halide
ion via the tunnel to the active-site tryptophans, and in this
respect it resembles more the accession of an internal cavity
by a small molecule or a halide translocation process in a
carrier than a tight binding step involving side-chain motion
or loop closure. The access of small molecules to an internal
cavity in an enzyme has been proposed to follow a rugged
energy profile along the binding coordinate, during which
conformational fluctuations provide stabilizing interactions
along the reaction coordinate (46, 50). A similar rugged
landscape with various stabilized intermediates has been
proposed for chloride ion transport in halorhodopsin (51).
The observed collision complex in haloalkane dehalogenase
may represent a relatively stable and rapidly formed first
intermediate along such a binding pathway or the last
intermediate if halide export is considered.
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